According to the CDC, about 1 out of every 200 babies is born with congenital CMV and about 1 out of 5 of these babies
will have birth defects or other long-term health problems.
Clinical Research Institute is conducting a research study for a vaccine to protect against CMV in women age 16 to 40.
Read more.
Pediatric Trials For Moderna’s COVID-19 Vaccine Have Begun In Minneapolis
Watch the video from WCCO Channel 4 News below or read more on WCCO's website.
Read more.
Dr Berman talks to Channel 5 news about the ongoing Moderna adolescent vaccine trial.
Read more.
Clinical Research Institute was chosen to lead the vaccine study in adolescents.
This study will look at the efficacy of the Moderna COVID-19 vaccine compared to placebo in adolescents, age 12 to 17.
"We're working as fast and diligently as we can to get volunteers scheduled, enrolled and we're going to be following them for the next 13 months," said Dr. Berman.
COVID-19 Adolescent Vaccine Trial
We are currently looking for healthy adolescents aged 12-17 to participate in a clinical trial for a Covid-19 vaccine. The study is evaluating the effectiveness of this vaccine at preventing illness after exposure to the SARS-CoV-2 virus, which causes COVID-19.
Read more.
Here's a great video from Twin Cities Live on the important impact of migraine research, featuring one of our doctors Gary Berman.
Read more.
We are grateful for the hard work of hospital staff, first responders, and the researchers and patient volunteers who are making clinical trials for a COVID-19 vaccine happen right now!
https://www.facebook.com/MNClinicalResearch/videos/2761624253946486/
Read more.
New research in the New England Journal of Medicine finds Rimegepant successfully relieves pain and other symptoms, including nausea and light sensitivity.
New Help for Migraines
Read more.
Dr. Allan Stillerman on KARE11_25MAR2019
Read more.
Clinical Research Institute along with Allergy & Asthma Specialists, wish to thank all of our past conference attendees for their participation in our annual conference.
We want to inform you that our annual conference in 2018 was our final conference. We have enjoyed providing this educational opportunity to healthcare providers for the past 20 years.
Please contact us if we can be of assistance to you as you continue caring for those you serve.
Check our Current Studies page for our currently enrolling research studies.
Read more.
Dr. Stillerman discussing new peanut allergy treatment on FOX9 News, November 19. 2018
Doctors Optimistic about new treatment for peanut
Read more.
